Bipartisan Lifesaving AIDS Relief Plan At Risk Due to Pro-Life Opposition

PEPFAR also targets tuberculosis and malaria, and funding restrictions could allow these diseases to gain a foothold.

Read the full post on Forbes - Healthcare